Abaloparatide Comparator Trial In Vertebral Endpoints (ACTIVE) confirms that abaloparatide is a valuable addition to the armamentarium against osteoporosis-Reference-Cited by-同舟云学术

Abaloparatide Comparator Trial In Vertebral Endpoints (ACTIVE) confirms that abaloparatide is a valuable addition to the armamentarium against osteoporosis

Published:2017-11-14 Issue:17 Volume:18 Page:1811-1813
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Reginster Jean-Yves¹²,Al Daghri Nasser Mohammad²³,Bruyere Olivier¹²

Affiliation:

1. Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium

2. WHO Collaborating Center for Public Health Aspects of Musculoskeletal Health and Aging, Liège, Belgium

3. Biochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia

Funder

funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1395021

Reference8 articles.

1. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis

2. Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling

3. Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men

4. The Use of Placebo-Controlled and Non-inferiority Trials for the Evaluation of New Drugs in the Treatment of Postmenopausal Osteoporosis

5. European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined and sequential therapies with anabolic and antiresorptive drugs in the management of patients with postmenopausal osteoporosis;International Journal of Bone Fragility;2023-06-01

2. β-Arrestin 2 knockout prevents bone loss in response to continuous parathyroid hormone stimulation in male and female mice;Connective Tissue Research;2023-04-12

3. Pharmacological Treatment of Patients with Osteoporosis;Senior Trauma Patients;2022

4. Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society;Menopause;2021-09

5. Clinical Application of Teriparatide in Fracture Prevention;JBJS Reviews;2019-01